U.S. equities traded mixed midway through Wednesday’s session. Lowe’s Companies stock gained around 5% after adjusted second-quarter 2026 earnings rose 1.6% to $4.40 per share, beating the $4.22 estimate, while sales increased 8.3% to $25.96 billion but fell short of the $26.16 billion forecast. The company narrowed its full-year outlook below Wall Street estimates. Moderna surged 145% after a Phase 3 trial with Merck met its primary and a key secondary endpoint, while Tenon Medical jumped 114% after receiving a U.S. patent allowance. Estee Lauder rose 16% on stronger-than-expected results and FY27 guidance, while WhiteFiber, Datavault AI and CID HoldCo declined on financing, earnings, acquisition, listing and loan-default developments. Oil, gold and silver rose, while copper fell. European shares were mixed and most Asian markets closed lower. Mortgage applications fell 0.4% in the second week of August, while U.S. crude inventories rose by 4.405 million barrels to 428.8 million barrels in the week ended Aug. 14.